These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12190952)

  • 21. Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form.
    Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
    Clin Chim Acta; 1990 Oct; 191(1-2):1-14. PubMed ID: 2150013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
    Brueckmann M; Bertsch T; Hoffmann U; Lang S; Kaden JJ; Wolpert C; Huhle G; Borggrefe M; Haase KK
    Clin Chem Lab Med; 2004; 42(8):896-902. PubMed ID: 15387439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
    van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
    Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial plasma ANP and NH2-terminal proANP during right atrial pressure increase in humans.
    Arjamaa O; Karlqvist K; Vainionpää V; Leppäluoto J; Vuolteenaho O
    Acta Physiol Scand; 1996 Aug; 157(4):481-5. PubMed ID: 8869731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
    Clerico A; Caprioli R; Del Ry S; Giannessi D
    J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
    Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
    Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
    Luers C; Sutcliffe A; Binder L; Irle S; Pieske B
    Clin Biochem; 2013 Aug; 46(12):1013-1019. PubMed ID: 23542086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age.
    Holmström H; Hall C; Stokke TO; Thaulow E
    Scand J Clin Lab Invest; 2000 Apr; 60(2):149-59. PubMed ID: 10817402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
    Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
    Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O; Frandsen E; Magnusson M; Grubb A; Jovinge S; Groop L
    J Intern Med; 2005 Mar; 257(3):281-8. PubMed ID: 15715685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NT-proANP and BNP in renovascular and in severe and mild essential hypertension.
    Mussalo H; Vanninen E; Ikäheimo R; Hartikainen J
    Kidney Blood Press Res; 2003; 26(1):34-41. PubMed ID: 12697975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
    Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC
    Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.